RecruitingNANCT07077057

Ticino Artificial InTelligence integrAtioN for Occlusion Myocardial Infarction

Sponsor: Cardiocentro Ticino

Trial Details

Condition	Myocardial Infarction (MI), Acute Coronary Syndrome (ACS)
Intervention	AI-assisted ECG interpretation (PMcardio)
Phase	NA
Status	Recruiting
Participants	500
Est. Completion	1 Aug 2027
Last Updated	5 May 2026

Primary Outcome

Hierarchical primary endpoint

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. Symptoms suspected of ongoing acute myocardial ischemia: Patients presenting with symptoms such as chest pain, dyspnoea, sweating, nausea or vomiting, pain radiating to the shoulder/arm/jaw/back, fatigue, or light-headedness 2. Age: Patients aged 18 years or older. 3. Informed Consent: Patients able to provide informed consent Exclusion Criteria: 1. Clear diagnosis of ST-segment elevation MI (STEMI) according to managing physicians. 2. Pregnancy or Lactation. 3. Legally incompetent to provide informed consent. 4. Symptoms onset\>24 hrs prior to clinical presentation.

Trial Sites

Countries

Switzerland

View Registry Entry

Related Analysis

Phase IV Trial Opens: AI-Assisted ECG Interpretation for Occult Myocardial Infarction — Early Detection Beyond Traditional STEMI Criteria

The TITAN-OMI trial evaluates AI-assisted ECG interpretation for detecting occult coronary occlusions in patients with acute coronary syndrome symptoms who don't meet traditional STEMI criteria. This Swiss study could revolutionise emergency cardiac care by identifying high-risk patients requiring urgent intervention.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service